Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Tainted By Lawsuits, Avoid Ripple Despite Recent Rise

Avoid Ripple and XRP crypto tokens, tainted by lawsuits, despite their recent rise. The value of Ripple cryptocurrency is hard to determine as the SEC and other lawsuits will taint it for many years.

Riot Blockchain Blows Through Numbers, Implying the Stock Could Rise

Overall, Riot Blockchain blows through numbers -- implying RIOT stock could rise to new heights for these reasons.

Oracle Is a Cash Cow Software Company Whose Stock Is Undervalued

Oracle is a cash cow software company whose stock is undervalued. ORCL stock is worth $126.75 or about 65% more based on comp-based FCF yield and P/E metrics.

PayPal’s Growth in Accounts and Payment Volume Will Push PYPL Stock Higher

PayPal's growth in payment volume will push PYPL stock higher -- potentially up 16.7% to $318.57 in 2022. Investors should look to buy now.

Twitter’s Free Cash Flow Recovery Should Lead to a 29% Increase

Twitter's free cash flow will recover this year, pushing TWTR stock higher. TWTR stock is worth $93.72, 29% higher, based on a recovery in its FCF margins and a lower FCF yield in 2 years.

Ocugen Stock Still Has a Good Chance of Making Money for Investors

Ocugen stock still has a good chance of rising. OCGN stock is worth at least 18% more based on scenario and probability analysis.

Don’t Expect Much From IBM Stock Over the Next 5 Years

IBM stock has gone nowhere over 5 years. IBM stock is down 12% in five years, but will rise 10% annually in next 5 using FCF yield analysis.

Roku Stock Could Falter From a High Valuation and Lower TV Streaming

Roku stock flies at a sky-high valuation but could crash if sales slow. Roku could falter given its valuation and if its sales slow after Covid restrictions reduce TV streaming.

Nike Stock Looks to Be Fairly Valued According to Fundamentals

At 42 times earnings Nike stock looks like it is fairly valued. NKE stock is not worth buying now although it may become a bargain if its Chinese sales dip.

MicroVision Stock Has Limited Upside Until it Has a Product in Hand

MicroVision is up for sale, but MVIS stock won’t rise until MicroVision actually produces its long-range Lidar sample.